biomolecules including DNA or PNA.12 In this work,
cysteine served as the ligation handle. However, the incor-
poration of cysteine in a convergent PNA-PNA fragment
coupling reaction would significantly distort the PNA
backbone and would hence reduce the affinity for target
nucleic acids. We hereby report the synthesis of a new
mercaptomethyl-modified PNA-monomer that allows the
application of native chemical ligation-like fragment coupling
reactions without detriment to backbone geometry. It is
shown that the DNA affinity of the PNA ligation products
is as high as the affinity of nonmodified PNA obtained by
linear solid-phase synthesis. Furthermore, rapid and efficient
fluorescence labeling of the ligation products is demonstrated.
The presented convergent approach enables the concise and
high-yielding synthesis of long fluorescently labeled PNA.
To enable PNA-fragment condensations by NCL-like
reactions a PNA-monomer is required that contains a
1-amino-2-thiol structure analogous to cysteine. We designed
the new PNA-monomer 1 as a structure analogue of a PNA
adenine monomer 2 (Figure 1). The introduction of amino
Scheme 1. Synthesis of Protected PNA Monomer 8 Suitable
for Native Chemical Ligation
yield. We next sought a method to couple 6-N-(benzyloxy-
carbonyl)-9-(carboxymethyl)adenine15 to the unreactive sec-
ondary amine in 6. Here, the use of pivaloyl chloride under
dry conditions proved superior to peptide couplings promoted
by carbodiimides, PyBOP, or HATU. The fully protected
mercaptomethyl adenine monomer 7 was obtained in 78%
yield. Finally, the methyl ester was saponified by treatment
with aqueous LiOH in THF, which completed a five-step
sequence and provided the optically active mercaptomethyl-
PNA monomer 8 in 52% overall yield.
The 1-amino-2-thiol-protected PNA-monomer 8 was next
employed in the solid-phase synthesis of PNA. Starting from
Fmoc-Gly-loaded MBHA-resin, Boc/Cbz-protected PNA
building blocks were assembled according to the Boc-strategy
(Scheme 2). After coupling of Boc/Trt/Cbz-protected adenine
building block 8 the Boc- and Trt-groups were removed by
adding TFA/m-cresol prior to treatment with TFMSA/TFA/
m-cresol required for Cbz and resin cleavage. Application
of this two-step protocol prevented the formation of tritylated
crude products observed in global deprotections with TFMSA/
TFA mixtures containing m-cresol, thioanisol, or triisopro-
pylsilane. The desired PNA conjugates 11, 12, and 13 were
obtained in 26%, 9%, and 4% overall yield, respectively,
after HPLC purification.
Figure 1. Structures of the PNA adenine monomer 2 and the
analogue 1 containing the 1-amino-2-thiol structure needed for
native chemical ligation-like reactions.
acid side chains such as from alanine, lysine, or arginine
into the PNA backbone has been reported.13 Surprisingly,
thiol groups have not been connected to the aminoethyl-
glycine scaffold. The envisaged application called for N-
terminal coupling of mercaptomethyl-modified PNA mono-
mer 1. It was therefore planned to employ acid-labile
protecting groups shown in Boc/Trt/Cbz-adenine monomer
8 which can be removed during the acid cleavage step of
Boc-based solid-phase PNA synthesis (Scheme 1). The
synthesis commenced from Boc/Trt-cysteine 3 which was
activated as a mixed anhydride by addition of isobutylchloro-
formate to enable the formation of the “Weinreb amide” 4.
Reduction with lithium aluminum hydride furnished the
corresponding aldehyde 5 in nearly quantitative overall
yield.14 This aldehyde was used in a reductive amination
reaction with glycine methyl ester hydrochloride, which
delivered the desired PNA-backbone building block 6 in 72%
The solid-phase synthesis of PNA-thioesters such as 14
presents a challenge.16 Most commonly, peptide thioesters
are prepared according to the Boc-strategy by using mer-
captopropionyl-based linkers.17 However, PNA-thioesters are
(14) Graham, S. L.; deSolms, S. J.; Giuliani E. A.; Kohl, N. E.; Mosser,
S. D.; Oliff, A. I.; Pompliano D. L.; Rands E.; Breslin, M. J.; Deana, A.
A.; Garsky, V. M.; Scholz, T. H.; Gibbs, J. B.; Smith, R. L. J. Med. Chem.
1994, 37, 725.
(15) Thomson, S. A.; Josey, J. A.; Cadilla, R.; Gaul, M. D.; Hassman,
C. F.; Luzzio, M. J.; Pipe, A. J.; Reed, K. L.; Ricca, D. J.; Wiethe, R. W.;
Noble, S. A. Tetrahedron 1995, 51, 6179.
(16) de Koning, M. C.; Filippov, V. D.; van der Marel, G. A.; van Boom,
J. H.; Overhand, M. Tetrahedron Lett. 2003, 44, 7597.
(17) Hackeng, T. M.; Griffin J. H.; Dawson. P. E. Proc. Natl. Acad. Sci.
U.S.A. 1999, 96, 10068.
(12) (a) Stetsenko D. A.; Gait, M. J. J. Org. Chem. 2000, 65, 4900. (b)
de Koning, M. C.; van der Knaap, M.; Petersen, L.; van den Elst, H.; van
der Marel, G. A.; Overhand, M.; Filippov, D. V. Synlett 2005, 4, 595. (c)
de Koning M. C.; Filippov D. V.; van der Marel G. A.; van Boom J. H.;
Overhand M. Eur. J. Org. Chem. 2004, 4, 850.
(13) (a) Kosynkina, L.; Wang, W.; Liang, T. C. Tetrahedron Lett. 1994,
35, 5173. (b) Pu¨schl, A.; Sforza, S.; Haaima, G.; Dahl, O.; Nielsen, P. E.
Tetrahedron Lett. 1998, 39, 4707.
4366
Org. Lett., Vol. 7, No. 20, 2005